Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $114.55 million. The enterprise value is $81.11 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 38.31 million shares outstanding. The number of shares has increased by 6.17% in one year.
| Current Share Class | 38.31M |
| Shares Outstanding | 38.31M |
| Shares Change (YoY) | +6.17% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 3.54% |
| Owned by Institutions (%) | 20.98% |
| Float | 17.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.78 |
| Forward PS | 33.82 |
| PB Ratio | 6.80 |
| P/TBV Ratio | 6.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 28.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.98.
| Current Ratio | 3.35 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -90.64 |
Financial Efficiency
Return on equity (ROE) is -179.12% and return on invested capital (ROIC) is -93.36%.
| Return on Equity (ROE) | -179.12% |
| Return on Assets (ROA) | -60.70% |
| Return on Invested Capital (ROIC) | -93.36% |
| Return on Capital Employed (ROCE) | -157.93% |
| Revenue Per Employee | $41,229 |
| Profits Per Employee | -$947,371 |
| Employee Count | 70 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.81% in the last 52 weeks. The beta is 0.63, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -62.81% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 4.57 |
| Relative Strength Index (RSI) | 47.21 |
| Average Volume (20 Days) | 236,839 |
Short Selling Information
The latest short interest is 1.21 million, so 3.16% of the outstanding shares have been sold short.
| Short Interest | 1.21M |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 3.16% |
| Short % of Float | 7.02% |
| Short Ratio (days to cover) | 5.26 |
Income Statement
In the last 12 months, OBIO had revenue of $2.89 million and -$66.32 million in losses. Loss per share was -$1.77.
| Revenue | 2.89M |
| Gross Profit | 2.67M |
| Operating Income | -68.80M |
| Pretax Income | -51.64M |
| Net Income | -66.32M |
| EBITDA | -68.48M |
| EBIT | -68.80M |
| Loss Per Share | -$1.77 |
Full Income StatementBalance Sheet
The company has $49.88 million in cash and $16.44 million in debt, giving a net cash position of $33.44 million or $0.87 per share.
| Cash & Cash Equivalents | 49.88M |
| Total Debt | 16.44M |
| Net Cash | 33.44M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 16.86M |
| Book Value Per Share | 0.44 |
| Working Capital | 36.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$54.06 million and capital expenditures -$393,000, giving a free cash flow of -$54.45 million.
| Operating Cash Flow | -54.06M |
| Capital Expenditures | -393,000 |
| Free Cash Flow | -54.45M |
| FCF Per Share | -$1.42 |
Full Cash Flow StatementMargins
| Gross Margin | 92.58% |
| Operating Margin | -2,383.89% |
| Pretax Margin | -2,297.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.17% |
| Shareholder Yield | -6.17% |
| Earnings Yield | -57.89% |
| FCF Yield | -47.53% |
Analyst Forecast
The average price target for OBIO is $14.20, which is 374.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.20 |
| Price Target Difference | 374.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 85.13% |
| EPS Growth Forecast (5Y) | -21.00% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of -7.86 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.86 |
| Piotroski F-Score | 3 |